Search

everythinglearnresearchcommunity

for

Search:↓

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Cepharanthine shows promise as a COVID-19 treatment.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Some people have severe allergic reactions to anthelminthic drugs, but these are often due to the parasites, not the drugs.

A capuchin monkey with a skin infection was successfully treated with itraconazole.

The rash resolved after stopping ponatinib.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

MK-5108 is safe and shows potential against tumors, especially alone.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

34% of patients on hepatitis C treatment had reversible skin issues.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Tofacitinib treatment is used for teenagers with alopecia areata.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Indinavir can cause hair loss and other skin problems.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.